Jill Bhakhri
Optometrist · Fontana, CANPI 1710235619
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $453, 2.2 times the $203 reported in 2019.
Across 75 payments — averaging $22.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$390
- Bausch & Lomb Americas Inc.$207
- Rxsight Inc$197
- Harrow Eye, LLC$117
- Alcon$110
- Glaukos Corporation$96
- plus $606 from 13 others
What the payments were for
- Food & beverage$1,723100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 25 | $390 |
| Bausch & Lomb Americas Inc. | 9 | $207 |
| Rxsight Inc | 3 | $197 |
| Harrow Eye, LLC | 5 | $117 |
| Alcon | 5 | $110 |
| Glaukos Corporation | 1 | $96 |
| Coopervision Inc. | 2 | $90 |
| AbbVie(2 entities) | 4 | $87 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $85 |
| Tarsus Pharmaceuticals, Inc. | 3 | $67 |
| Oyster Point Pharma, Inc. | 2 | $50 |
| Sun Pharmaceutical Industries Inc. | 2 | $45 |
| Aerie Pharmaceuticals, Inc. | 2 | $36 |
| Kala Pharmaceuticals, Inc. | 1 | $36 |
| Optovue, Inc. | 1 | $29 |
| Ocular Therapeutix, Inc. | 1 | $24 |
| Thea Pharma Inc. | 1 | $23 |
| Shire North American Group Inc | 1 | $18 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $15 |
How this compares
$1,723 in reported general payments places this provider in the 75th percentile of 6,778 optometrist providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 128 | $158,440 |
| XiidraLifitegrast | 28 | $40,168 |
| XdemvyLotilaner | 17 | $30,715 |
| TyrvayaVarenicline Tartrate | 25 | $16,371 |
| RocklatanNetarsudil Mesylat/Latanoprost | 24 | $14,207 |
| ProlensaBromfenac Sodium | 31 | $12,437 |
| Cyclosporine | 34 | $11,696 |
| MieboPerfluorohexyloctane/Pf | 12 | $9,116 |
| Alphagan PBrimonidine Tartrate | 14 | $7,134 |
| RhopressaNetarsudil Mesylate | 13 | $5,873 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 22 | $4,914 |
| Latanoprost | 278 | $4,595 |
| Prednisolone Acetate | 87 | $3,239 |
| Travoprost | 15 | $2,570 |
| Timolol Maleate | 113 | $2,379 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Alphagan P | $87 | $165,574142 claims |
| Bausch & Lomb Americas Inc.Xiidra, Miebo | $207 | $49,28440 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $67 | $30,71517 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $36 | $20,08037 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $50 | $16,37125 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa | $85 | $12,43731 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,778 optometrist providers in California.
Other optometrist in Fontana
- Jason FloresFontana$60K
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
- Jason TuSan Diego$351K
- Scott SchachterPismo Beach$312K
- Alicia LauSan Diego$300K
- Vin DangBakersfield$284K
- Steven FerrucciSepulveda$272K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.